For the quarter ending 2025-09-30, LFST had $14,974K increase in cash & cash equivalents over the period. $16,996K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net loss | 1,077 | -3,791 | 709 | -7,112 |
| Depreciation and amortization | 13,557 | 14,006 | 13,756 | 14,671 |
| Non-cash operating lease costs | 10,596 | 10,438 | 10,231 | 10,071 |
| Stock-based compensation | 18,297 | 21,116 | 18,584 | 16,146 |
| Deferred income taxes | - | - | - | -958 |
| Loss on debt extinguishment | - | - | - | -5,032 |
| Amortization of discount and debt issue costs | 256 | 255 | 251 | 402 |
| Gain on remeasurement of contingent consideration | 0 | 0 | 0 | -250 |
| Other, net | -687 | -396 | -357 | -433 |
| Patient accounts receivable, net | -8,411 | -10,886 | 8,568 | -26,360 |
| Prepaid expenses and other current assets | -4,769 | 10,664 | 4,515 | -592 |
| Accounts payable | 3,145 | -200 | -77 | -119 |
| Accrued payroll expenses | -15,414 | 29,265 | -17,540 | 5,603 |
| Operating lease liabilities | -12,331 | -11,604 | -11,894 | -12,448 |
| Other accrued expenses | -5,763 | 4,293 | -4,386 | 3,393 |
| Net cash provided by operating activities | 27,287 | 64,396 | -3,092 | 62,316 |
| Purchases of property and equipment | 10,291 | 7,755 | 7,168 | 6,301 |
| Acquisitions of businesses, net of cash acquired | - | - | - | 0 |
| Net cash used in investing activities | -10,291 | -7,755 | -7,168 | -6,301 |
| Proceeds from long-term debt, net of discount | - | - | - | 287,809 |
| Payments of debt issue costs | - | - | - | 1,818 |
| Payments of long-term debt | 1,813 | 1,812 | 1,813 | 287,300 |
| Prepayment for debt paydown | - | - | - | 0 |
| Payments of contingent consideration | 0 | 0 | 0 | 2,750 |
| Taxes related to net share settlement of equity awards | 209 | 236 | 8,162 | 0 |
| Net cash used in financing activities | -2,022 | -2,048 | -9,975 | -4,059 |
| Net increase in cash and cash equivalents | 14,974 | 54,593 | -20,235 | 51,956 |
| Cash and cash equivalents at beginning of period | 188,929 | 134,336 | 154,571 | 102,615 |
| Cash and cash equivalents at end of period | 203,903 | 188,929 | 134,336 | 154,571 |
LifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. (LFST)